Core Insights - WesBanco reported a revenue of $265.57 million for the quarter ended December 2025, marking a 63% increase compared to the same period last year [1] - The earnings per share (EPS) for the quarter was $0.84, an increase from $0.71 in the previous year [1] - The reported revenue was slightly below the Zacks Consensus Estimate of $265.71 million, resulting in a surprise of -0.05% [1] - The company met the consensus EPS estimate of $0.84, indicating no surprise in earnings [1] Key Metrics - Total earning assets averaged $24.55 billion, slightly below the estimated $24.74 billion [4] - The efficiency ratio was reported at 51.6%, better than the average estimate of 54.4% [4] - The net interest margin was consistent at 3.6%, matching the average estimate [4] - Mortgage banking income was reported at $0.79 million, significantly lower than the average estimate of $1.95 million [4] - Total non-interest income was $43.27 million, slightly below the average estimate of $43.35 million [4] Stock Performance - WesBanco shares have returned +2.8% over the past month, outperforming the Zacks S&P 500 composite, which saw a +0.4% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Core Insights - Celanese reported revenue of $2.53 billion for the quarter ended June 2025, a decrease of 4.5% year-over-year, but exceeded the Zacks Consensus Estimate by 1.42% [1] - Earnings per share (EPS) was $1.44, down from $2.38 in the same quarter last year, and surpassed the consensus estimate of $1.38 by 4.35% [1] Financial Performance - Net Sales from the Acetyl Chain were $1.12 billion, exceeding the average estimate of $1.1 billion, but reflecting a year-over-year decline of 7.2% [4] - Net Sales from Inter segment eliminations were reported at -$25 million, worse than the estimated -$20.32 million, but showed a significant year-over-year increase of 38.9% [4] - Net Sales from Engineered Materials reached $1.44 billion, above the average estimate of $1.35 billion, with a slight year-over-year decline of 1.7% [4] - Operating EBITDA for the Acetyl Chain was $260 million, below the average estimate of $287.13 million [4] - Operating EBITDA for Other Activities was -$54 million, slightly better than the average estimate of -$56.51 million [4] - Operating EBITDA for Engineered Materials was $326 million, exceeding the average estimate of $278.5 million [4] Stock Performance - Celanese shares have declined by 21.3% over the past month, contrasting with a 2.7% increase in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]